sales@scalarmarketresearch.com  |   +1-800-213-5170  (U.S./ Canada Toll-free)  |  REGISTER |  SIGN IN

Home >> Reports >> biomarkers market

report

Biomarkers Market, by Types (Disease, Exposure), Applications (Risk Assessment, Molecular Diagnostics, Disease Diagnostics, Drug Discovery & Development, Forensics), Services (Sample Preparation, Assay Development, Biomarker Validation) - Global Revenue, Trends, Growth, Share, Size and Forecast to 2022

HC197 December 2016 100+ FREE 10% CUSTOMIZATION

The objective of this report is to describe the market trends and revenue forecasts for the biomarkers market for the next five years. The report focuses on defining and describing the key influencing factors for the growth of the market. It also offers an in-depth analysis of the market size (revenue), market share, major market segments, different geographic regions, key market players, and premium industry trends.

The report tracks the major market events including product launches, technological developments, mergers & acquisitions, and the innovative business strategies opted by key market players. Along with strategically analyzing the key micro markets, the report also focuses on industry-specific drivers, restraints, opportunities and challenges in the biomarkers market. The scope of this report covers the biomarkers market by its major segments, which include the applications, services, and the major geographic regions.

KEY BENEFITS OF THE REPORT

  • In-depth analysis of the market segments that will showcase the greatest growth potential
  • Information about the technological advancements influencing the growth of the global market
  • Extensive analysis of the key players dominating the competitive landscape of this market

KEY PREMIUM INDUSTRY INSIGHTS

  • The rising demand for personalized medicines, increase in the prevalence of the chronic diseases, and increasing healthcare spending across the world are the major drivers for the biomarkers market.
  • The use of biomarkers by pharmaceuticals companies as proxies for disease models is also fuelling the market growth.
  • However, the requirement of high capital investment for the discovery and validation of the new applications is expected to restrain the growth of the biomarkers market.

RESEARCH METHODOLOGY

The research methodology for Scalar Market Research’s biomarkers market report utilizes a combination of top-down and bottom-up research formats. Our primary focus on continuous market tracking, rigorous fact-checking, data-triangulation, and multiple layers of quality control ensures high-quality data that can be leveraged for actionable research insights.

To know about the assumptions considered for the study, Download PDF Sample.

MARKET SEGMENTATION

This report analyzes the biomarkers market by the following segments:

  • Biomarkers Market, by Types
    • Biomarker of Disease
    • Biomarker of Exposure
  • Biomarkers Market, by Applications
    • Risk Assessment
    • Development of Molecular Diagnostic
    • Disease Diagnostic
    • Drug Discovery and Development
    • Forensic Application
  • Biomarkers Market, by Services
    • Sample Preparation
    • Assay Development
    • Biomarker Validation and Testing

KEY MARKET PLAYERS

Key players in the biomarkers market include:

  • Qiagen N.V.
  • Merck & Co., Inc.
  • EKF Diagnostics
  • PerkinElmer Inc.
  • Bio-Rad Laboratories, Inc.
  • Enzo Biochem Inc.
  • Meso Scale Diagnostics LLC
  • Singulex, Inc.
  • Biosims

GEOGRAPHIC COVERAGE AND ANALYSIS

This granular market research report covers the following geographic regions in great detail:

  • NORTH AMERICA
    • U.S.
    • Rest of North America
  • EUROPE
    • France
    • Germany
    • U.K.
    • Rest of Europe
  • ASIA-PACIFIC
    • China
    • India
    • Japan
    • Rest of Asia-Pacific
  • REST OF THE WORLD
    • Latin America
    • Middle East & Africa

Biomarkers Market

TRENDING RELATED REPORT

Biosimilars Market, by Product Types (Recombinant Glycosylated Proteins, Recombinant Non-Glycosylated Proteins, Recombinant Peptides), Applications (Oncology, Blood Disorders, Infectious Diseases, Autoimmune Diseases, and Others) - Global Revenue, Trends, Growth, Share, Size and Forecast to 2022


  1. MARKET OVERVIEW
    1. Market Definition
    2. Research Methodology
    3. Market Segmentation
  2. EXECUTIVE SUMMARY
  3. MARKET DYNAMICS
    1. Drivers
    2. Restraints
    3. Opportunities
    4. Premium Industry Trends
  4. INDUSTRY ANALYSIS
    1. Value Chain Analysis
    2. Technology Roadmap
    3. Ecosystem Analysis
  5. BIOMARKERS MARKET, BY TYPES
    1. Segment Share
    2. By Types
      1. Biomarker of Disease
      2. Biomarker of Exposure
  6. BIOMARKERS MARKET, BY APPLICATIONS
    1. Segment Share
    2. By Applications
      1. Risk Assessment
      2. Development of Molecular Diagnostic
      3. Disease Diagnostic
      4. Drug Discovery and Development
      5. Forensic Application
  7. BIOMARKERS MARKET, BY SERVICES
    1. Segment Share
    2. By Services
      1. Sample Preparation
      2. Assay Development
      3. Biomarker Validation and Testing
  8. BIOMARKERS MARKET, BY GEOGRAPHY
    1. North America
      1. By Regions
        1. U.S.
        2. Rest of North America
      2. By Types
      3. By Applications
      4. By Services
    2. Europe
      1. By Regions
        1. France
        2. Germany
        3. U.K.
        4. Rest of Europe
      2. By Types
      3. By Applications
      4. By Services
    3. Asia-Pacific
      1. By Regions
        1. China
        2. India
        3. Japan
        4. Rest of Asia-Pacific
      2. By Types
      3. By Applications
      4. By Services
    4. Rest of the World
      1. By Regions
        1. Latin America
        2. Middle East & Africa
      2. By Types
      3. By Applications
      4. By Services
  9. COMPETITIVE LANDSCAPE
  10. KEY MARKET PLAYERS
    1. Qiagen N.V.
      1. Overview
      2. Key Strategies
      3. Recent Developments
    2. Merck & Co., Inc.
      1. Overview
      2. Key Strategies
      3. Recent Developments
    3. EKF Diagnostics
      1. Overview
      2. Key Strategies
      3. Recent Developments
    4. PerkinElmer Inc.
      1. Overview
      2. Key Strategies
      3. Recent Developments
    5. Bio-Rad Laboratories, Inc.
      1. Overview
      2. Key Strategies
      3. Recent Developments
    6. Enzo Biochem Inc.
      1. Overview
      2. Key Strategies
      3. Recent Developments
    7. Meso Scale Diagnostics LLC
      1. Overview
      2. Key Strategies
      3. Recent Developments
    8. Singulex, Inc.
      1. Overview
      2. Key Strategies
      3. Recent Developments
    9. Biosims
      1. Overview
      2. Key Strategies
      3. Recent Developments
  11. SCALAR 360 DEGREE MARKET PERSPECTIVE
  12. APPENDIX
Please submit your enquiry below so our representative can get in touch with you
*
*
*
*
*
*

USA - CANADA TOLL FREE
+1-800-213-5170
EMAIL
sales@scalarmarketresearch.com

Benefits of Buying From Scalar

  • Unparalleled Expertise

    Our industry experts hold inimitable know-how across wide range of industry verticals

  • Assured Quality

    We deliver high-quality, real-time and data-driven industry insights to our clients

  • 24x7 Analyst Support

    We offer pre-purchase and post-purchase support from our industry experts

  • Privacy & Security

    All your personal information and confidential details are safe and secure with us